SCHEMBL5728630

SCHEMBL5728630

O=C(CBr)CCn1cc2ccccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.37
GSK3B P49841 2/20 0.35
CPA1 P15085 1/20 0.34
LMNA P02545 1/20 0.33
HPGD P15428 2/20 0.33
TSHR P16473 2/20 0.33
KMO O15229 1/20 0.33
MAPK1 P28482 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MTNR1A P48039 1/20 0.31
MTNR1B P49286 1/20 0.31
HDAC3 O15379 2/20 0.30
HDAC4 P56524 2/20 0.30
HDAC1 Q13547 2/20 0.30
HDAC7 Q8WUI4 2/20 0.30
HDAC2 Q92769 2/20 0.30
HDAC10 Q969S8 2/20 0.30
HDAC11 Q96DB2 2/20 0.30
HDAC8 Q9BY41 2/20 0.30
HDAC6 Q9UBN7 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7634312 0.79 KMO (0.50) LMNAKMOALDH1A1
SCHEMBL5729887 0.77 ALDH1A1 (0.44) LMNAHPGDTSHRKMOMAPK1
SCHEMBL27801037 0.77 LMNA (0.54) LMNAHPGDTSHRKMOMAPK1
SCHEMBL3632871 0.73 BCHE (0.34) TSHRALDH1A1
SCHEMBL7365093 0.72 FABP4 (0.51) KMOMAPK1ALDH1A1HDAC3HDAC4
SCHEMBL608395 0.72 LMNA (0.49) LMNAHPGDMAPK1ALDH1A1MTNR1A
SCHEMBL7633464 0.70 FABP4 (0.53) MAPK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL29452030 0.69 ALDH1A1 (0.54) HPGDTSHRALDH1A1HDAC3HDAC4
SCHEMBL133129 0.69 ALDH1A1 (0.54) HPGDTSHRALDH1A1HDAC3HDAC4
SCHEMBL377726 0.69 CDK4 (0.33) HPGDMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644320-A1 INDANE DERIVATES AS MUSCARINIC RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2006-04-12 EP disclosed
WO-2005009941-A1 INDANE DERIVATES AS MUSCARINIC RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2005-02-03 WO disclosed